About Britany
Britany Clarke has been a Business Development Manager at Cancer Research Horizons since April 2024.
In our Business Development Therapeutics team, Britany establishes licensing agreements and collaborations with industry to translate innovative cancer therapeutics into patient benefit.
In her role, Britany commercialises therapeutics emerging from Cancer Research UK's network of world-class researchers. She leads on the translation, marketing and licensing transactions for a diverse cancer therapeutic portfolio including multiple modalities such as; vaccines, oligonucleotides, targeted drug delivery, cell therapies, peptides, small molecules and antibodies. Britany also leads on strategic industry engagement showcase events.
Britany completed her multi-disciplinary Biotechnology undergraduate degree, Science Education postgraduate and PhD at the University of Nottingham. Her doctoral research focused on the discovery and development of novel peptides through the exploitation of in-silico pipelines, next-generation phage display, and advanced characterisation assays.
Prior to joining Cancer Research Horizons, Britany worked in the Technology Transfer Office at Imperial College London, managing patents and licensing plus supporting spin-out formation, she also successfully obtained multiple >£1m translational funding grants for Imperial's Faculty of Medicine.